-
Je něco špatně v tomto záznamu ?
Clear cell renal cell carcinoma with Paneth-like cells: Clinicopathologic, morphologic, immunohistochemical, ultrastructural, and molecular analysis of 13 cases
F. Kojima, S. Bulimbasic, R. Alaghehbandan, P. Martinek, T. Vanecek, K. Michalova, K. Pivovarcikova, M. Michal, M. Hora, SI. Murata, E. Sugawara, J. Rogala, R. Limani, O. Hes,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- dospělí MeSH
- imunohistochemie MeSH
- karcinom z renálních buněk patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory ledvin patologie MeSH
- Panethovy buňky patologie MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Clear cell renal cell carcinoma (CRCC) is well known for its intratumoral heterogeneity. Paneth-like cells (PLC) have been reported in variable organs (i.e., hepatobiliary, genitourinary, and female genital tract). In genitourinary system, it is possible to find PLCs in epididymis, urinary bladder and prostate. The objective of this study was to assess PLC in CRCCs 13 CRCCs with prominent PLC (CRCCPLC) were selected out of 1378 CRCCs in our registry. The tumors were analyzed using morphologic, immunohistochemical, ultrastructural, and molecular genetic methods. CRCCPLCs were mostly of low histologic grade (12/13). Immunohistochemical profile was compatible with classic CRCC. PLC constituted 10 to-70% of the tumor volume (mean 17.7%, median 10%). PLCs did not express neuroendocrine markers (chromogranin, synaptophysin, CD56, INSM-1). Ultrastructurally, PLCs were filled by membrane bounded vesicles of various sizes and were compatible with secretory type of cells. VHL mutation was found in 9/9 cases, and LOH3p was found in 6/8 analyzable cases. Conclusions: PLC morphology can variably be present in "classic" CRCC, even in a substantial proportion. Ultrastructurally, PLCs have all attributes of secretory cells. Preliminary follow up data showed that these tumors may not be associated with aggressive clinical behavior.
Clinical Department of Pathology and Cytology University Hospital Centre Zagreb Croatia
Department of Human Pathology Wakayama Medical University Wakayama Japan
Department of Pathology Charles University Prague Faculty of Medicine in Plzeň Pilsen Czech Republic
Department of Pathology Musashino Red Cross Hospital Tokyo Japan
Department of Urology Charles University Prague Faculty of Medicine in Plzeň Pilsen Czech Republic
Institute of Pathology Hospital and University Clinic Services of Kosovo Prishtina Kosovo
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006255
- 003
- CZ-PrNML
- 005
- 20200525141142.0
- 007
- ta
- 008
- 200511s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.anndiagpath.2019.05.012 $2 doi
- 035 __
- $a (PubMed)31202196
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kojima, Fumiyoshi $u Department of Human Pathology, Wakayama Medical University, Wakayama, Japan.
- 245 10
- $a Clear cell renal cell carcinoma with Paneth-like cells: Clinicopathologic, morphologic, immunohistochemical, ultrastructural, and molecular analysis of 13 cases / $c F. Kojima, S. Bulimbasic, R. Alaghehbandan, P. Martinek, T. Vanecek, K. Michalova, K. Pivovarcikova, M. Michal, M. Hora, SI. Murata, E. Sugawara, J. Rogala, R. Limani, O. Hes,
- 520 9_
- $a Clear cell renal cell carcinoma (CRCC) is well known for its intratumoral heterogeneity. Paneth-like cells (PLC) have been reported in variable organs (i.e., hepatobiliary, genitourinary, and female genital tract). In genitourinary system, it is possible to find PLCs in epididymis, urinary bladder and prostate. The objective of this study was to assess PLC in CRCCs 13 CRCCs with prominent PLC (CRCCPLC) were selected out of 1378 CRCCs in our registry. The tumors were analyzed using morphologic, immunohistochemical, ultrastructural, and molecular genetic methods. CRCCPLCs were mostly of low histologic grade (12/13). Immunohistochemical profile was compatible with classic CRCC. PLC constituted 10 to-70% of the tumor volume (mean 17.7%, median 10%). PLCs did not express neuroendocrine markers (chromogranin, synaptophysin, CD56, INSM-1). Ultrastructurally, PLCs were filled by membrane bounded vesicles of various sizes and were compatible with secretory type of cells. VHL mutation was found in 9/9 cases, and LOH3p was found in 6/8 analyzable cases. Conclusions: PLC morphology can variably be present in "classic" CRCC, even in a substantial proportion. Ultrastructurally, PLCs have all attributes of secretory cells. Preliminary follow up data showed that these tumors may not be associated with aggressive clinical behavior.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a karcinom z renálních buněk $x patologie $7 D002292
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a nádory ledvin $x patologie $7 D007680
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a Panethovy buňky $x patologie $7 D019879
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bulimbasic, Stela $u Clinical Department of Pathology and Cytology, University Hospital Centre Zagreb, Croatia.
- 700 1_
- $a Alaghehbandan, Reza $u Department of Pathology, Faculty of Medicine, University of British Columbia, Royal Columbian Hospital, Vancouver, BC, Canada.
- 700 1_
- $a Martinek, Petr $u Department of Pathology, Charles University in Prague, Faculty of Medicine in Plzeň, Pilsen, Czech Republic.
- 700 1_
- $a Vanecek, Tomas $u Department of Pathology, Charles University in Prague, Faculty of Medicine in Plzeň, Pilsen, Czech Republic.
- 700 1_
- $a Michalova, Kvetoslava $u Department of Pathology, Charles University in Prague, Faculty of Medicine in Plzeň, Pilsen, Czech Republic.
- 700 1_
- $a Pivovarcikova, Kristyna $u Department of Pathology, Charles University in Prague, Faculty of Medicine in Plzeň, Pilsen, Czech Republic.
- 700 1_
- $a Michal, Michal $u Department of Pathology, Charles University in Prague, Faculty of Medicine in Plzeň, Pilsen, Czech Republic.
- 700 1_
- $a Hora, Milan $u Department of Urology, Charles University in Prague, Faculty of Medicine in Plzeň, Pilsen, Czech Republic.
- 700 1_
- $a Murata, Shin-Ichi $u Department of Human Pathology, Wakayama Medical University, Wakayama, Japan.
- 700 1_
- $a Sugawara, Emiko $u Department of Pathology, Musashino Red Cross Hospital, Tokyo, Japan.
- 700 1_
- $a Rogala, Joanna $u Department of Pathology, Charles University in Prague, Faculty of Medicine in Plzeň, Pilsen, Czech Republic.
- 700 1_
- $a Limani, Rinë $u Institute of Pathology, Hospital and University Clinic Services of Kosovo, Prishtina, Kosovo.
- 700 1_
- $a Hes, Ondrej $u Department of Pathology, Charles University in Prague, Faculty of Medicine in Plzeň, Pilsen, Czech Republic. Electronic address: hes@medima.cz.
- 773 0_
- $w MED00166541 $t Annals of diagnostic pathology $x 1532-8198 $g Roč. 41, č. - (2019), s. 96-101
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31202196 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200525141141 $b ABA008
- 999 __
- $a ok $b bmc $g 1525113 $s 1096311
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 41 $c - $d 96-101 $e 20190603 $i 1532-8198 $m Annals of diagnostic pathology $n Ann. diagn. pathol. $x MED00166541
- LZP __
- $a Pubmed-20200511